Parallax Enterprises is dedicated to preventing medical errors by providing advanced systems that ensure critical patient information and procedural checklists are readily available in operating rooms. Their flagship product, CHaRM, is an OR system designed to display essential patient data and an electronic checklist of the procedure, enhancing accuracy and safety in surgical environments. The company focuses on the healthcare market, aiming to improve patient outcomes through innovative technology.
Parallax Enterprises has made significant strides in the medical technology field, with their CHaRM system being protected by a U.S. patent. The company's impact is evident in its contribution to reducing medical errors and improving operational efficiency in hospitals. Based in Pikesville, Maryland, Parallax Enterprises continues to innovate and lead in the healthcare sector, ensuring that critical patient information is always at the forefront of surgical procedures.
Quick Facts
When was Parallax Enterprises' last funding round?
Parallax Enterprises' most recent funding round was for $1M (USD) in March 2013.
How much disclosed funding has Parallax Enterprises raised?
As of Mar 25, 2013, Parallax Enterprises has disclosed funding of $1M (USD).